Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -20,613 | -17,806 |
| Depreciation Amortization | 935 | 1,042 |
| Accounts receivable | -188 | 1,181 |
| Accounts payable and accrued liabilities | 303 | -223 |
| Other Working Capital | -17,072 | -13,715 |
| Other Operating Activity | 503 | -381 |
| Operating Cash Flow | $-36,132 | $-29,902 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -193 | -1,031 |
| Purchase Of Investment | N/A | -8,025 |
| Sale Of Investment | 5,620 | 7,549 |
| Other Investing Activity | 119 | 0 |
| Investing Cash Flow | $5,546 | $-1,507 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 48 | 48 |
| Other Financing Activity | 0 | 37,857 |
| Financing Cash Flow | $48 | $37,905 |
| Exchange Rate Effect | 12 | -3 |
| Beginning Cash Position | 53,753 | 47,260 |
| End Cash Position | 23,227 | 53,753 |
| Net Cash Flow | $-30,526 | $6,493 |
| Free Cash Flow | ||
| Operating Cash Flow | -36,132 | -29,902 |
| Capital Expenditure | -193 | -1,031 |
| Free Cash Flow | -36,325 | -30,933 |